Skip to main content
. 2014 Nov;99(11):1701–1709. doi: 10.3324/haematol.2013.085977

Figure 1.

Figure 1.

The high-dose imatinib cohort. The figure shows data from four representative patients from the high-dose imatinib cohort, displaying the ratio of BCR-ABL1 to ABL1 plus one over time measured in months (broken line) as well as the exponential model (solid line).